Template

Show index

Template Product Instance 2015‑08‑13

Id2.16.840.1.113883.10.20.22.4.37
ref
ccda-
Gültigkeit ab2015‑08‑13
Statusdraft EntwurfVersions-Label2.1
NameProductInstanceBezeichnungProduct Instance
Beschreibung
en-US This clinical statement represents a particular device that was placed in a patient or used as part of a procedure or other act. This provides a record of the identifier and other details about the given product that was used. For example, it is important to have a record that indicates not just that a hip prostheses was placed in a patient but that it was a particular hip prostheses number with a unique identifier. The FDA Amendments Act specifies the creation of a Unique Device Identification (UDI) System that requires the label of devices to bear a unique identifier that will standardize device identification and identify the device through distribution and use. The FDA permits an issuing agency to designate that their Device Identifier (DI) + Production Identifier (PI) format qualifies as a UDI through a process of accreditation. Currently, there are three FDA-accredited issuing agencies that are allowed to call their format a UDI. These organizations are GS1, HIBCC, and ICCBBA. For additional information on technical formats that qualify as UDI from each of the issuing agencies see the UDI Appendix. When communicating only the issuing agency device identifier (i.e., subcomponent of the UDI), the use of the issuing agency OID is appropriate. However, when communicating the unique device identifier (DI + PI), the FDA OID (2.16.840.1.113883.3.3719) must be used. When sending a UDI, populate the participantRole/id/@root with the FDA OID (2.16.840.1.113883.3.3719) and participantRole/id/@extension with the UDI. When sending a DI, populate the participantRole/id/@root with the appropriate assigning agency OID and participantRole/id/@extension with the DI. The scopingEntity/id should correspond to FDA or the appropriate issuing agency.
KontextElternknoten des Template-Element mit Id 2.16.840.1.113883.10.20.22.4.37
KlassifikationCDA Entry Level Template
Offen/GeschlossenOffen (auch andere als die definierten Elemente sind erlaubt)
Benutzt von / Benutzt
Benutzt von 10 Transactions und 76 Templates, Benutzt 0 Templates
Benutzt von als NameVersion
2.16.840.1.113883.3.1937.99.3.4.29Transaktionfinal en-US Progress Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.21Transaktionfinal en-US Care Plan (V2)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.28Transaktionfinal en-US Procedure Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.23Transaktionfinal en-US Continuity of Care Document (CCD) (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.30Transaktionfinal en-US Referral Note (V2)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.27Transaktionfinal en-US Operative Note (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.31Transaktionfinal en-US Transfer Summary (V2)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.26Transaktionfinal en-US History and Physical (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.25Transaktionfinal en-US Discharge Summary (V3)2015‑08‑01
2.16.840.1.113883.3.1937.99.3.4.22Transaktionfinal en-US Consultation Note (V3)2015‑08‑01
1.3.6.1.4.1.19376.1.4.1.4.14Containmentdraft Procedure Activity Procedure - Cardiac (1.0)2017‑04‑12 20:35:17
1.3.6.1.4.1.19376.1.4.1.4.35Containmentdraft Procedure Activity Procedure Medical History - Cardiac (1.0)2017‑03‑21 20:50:51
2.16.840.1.113883.3.51.60.2.4linkpending BC CDA ClinicalDocumentDischargeSummary (V3) (2.1)2019‑03‑19 14:15:51
2.16.840.1.113883.3.51.60.3.35Containmentpending BC CDA Planned Supply (V2) (2.1)2019‑04‑29 09:05:58
2.16.840.1.113883.3.1937.99.61.20.10.9linkdraft Medications Section (entries required) (V2) (2.1)2015‑11‑03 08:58:06
2.16.840.1.113883.3.1937.99.61.21.10.20linkdraft NH MI (fake) Recommendation (2.1)2019‑07‑25 23:56:49
2.16.840.1.113883.3.1937.99.61.26.10.54Containmentrejected Procedure Activity Procedure (V2) (2.1)2019‑03‑06 15:52:43
2.16.840.1.113883.3.1937.99.61.26.10.55linkdraft Allergy - Intolerance Observation (V2) (2.1)2019‑03‑08 04:36:16
2.16.840.1.113883.3.1937.99.61.26.10.61linkdraft Allergy Concern Act (V3) (2.1)2019‑03‑09 13:34:13
2.16.840.1.113883.3.1937.99.61.26.10.62linkrejected Allergies and Intolerances Section (entries optional) (V3) (2.1)2019‑03‑09 13:37:11
2.16.840.1.113883.3.1937.99.61.26.10.112linkrejected Adverse Events Section (entries optional) (V3) (2.1)2019‑03‑25 06:01:02
2.16.840.1.113883.3.1937.99.61.26.10.114linkrejected Medication Activity (V2) (2.1)2019‑03‑31 19:39:09
2.16.840.1.113883.3.1937.99.61.26.10.121Containmentdraft Planned Supply (V2) (2.1)2019‑04‑29 09:00:08
2.16.840.1.113883.3.1937.99.61.26.10.122linkdraft Nutrition Recommendation (2.1)2019‑04‑29 09:01:33
2.16.840.1.113883.3.1937.99.61.28.10.3linkdraft CDA de Consulta (1)2017‑04‑22 23:20:01
2.16.840.1.113883.3.1937.99.61.30.10.54linkcancelled Health Concern Act (harmonized) (0.1)2020‑10‑08 10:55:41
2.16.840.1.113883.3.1937.99.61.30.10.58linkdraft _Allergy - Intolerance Observation (harmonization)) (wip)2020‑10‑16 15:17:11
2.16.840.1.113883.3.1937.99.61.30.10.60linkdraft _Immunization (harmonized) (IAT)2021‑07‑06 09:55:32
2.16.840.1.113883.3.1937.99.61.67.10.24linkcancelled XeH Alert Act2021‑04‑20 10:00:04
2.16.840.1.113883.3.1937.99.61.67.10.25linkcancelled XeH Risk Concern Act2021‑04‑20 10:06:56
2.16.840.1.113883.10.20.21.2.3linkdraft Interventions Section (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.2linkdraft Continuity of Care Document (CCD) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.3linkdraft History and Physical (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.4linkdraft Consultation Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.6linkdraft Procedure Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.7linkdraft Operative Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.8linkdraft Discharge Summary (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.9linkdraft Progress Note (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.13linkdraft Transfer Summary (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.14linkdraft Referral Note (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.1.15linkdraft Care Plan (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.1linkdraft Medications Section (entries optional) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.1.1linkdraft Medications Section (entries required) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.2linkdraft Immunizations Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.2.1linkdraft Immunizations Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.6linkdraft Allergies and Intolerances Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.6.1linkdraft Allergies and Intolerances Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.7linkdraft Procedures Section (entries optional) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.7linkpending Procedures Section (entries optional) (V2) (2.1)2019‑03‑16 21:12:43
2.16.840.1.113883.10.20.22.2.7.1linkdraft Procedures Section (entries required) (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.10linkdraft Plan of Treatment Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.10linkdraft Plan of Treatment Section (V2) (2.1)2019‑03‑16 08:54:08
2.16.840.1.113883.10.20.22.2.11linkdraft Discharge Medications Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.11.1linkdraft Discharge Medications Section (entries required) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.14linkdraft Functional Status Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.14linkpending Functional Status Section (V2) (2.1)2019‑03‑16 20:25:20
2.16.840.1.113883.10.20.22.2.23linkdraft Medical Equipment Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.25linkdraft Anesthesia Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.38linkdraft Medications Administered Section (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.2.44linkdraft Admission Medications Section (entries optional) (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.58linkdraft Health Concerns Section (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.2.78linkdraft BC CDA Medication Activity (V2) (2.1)2019‑03‑15 14:29:33
2.16.840.1.113883.10.20.22.2.80linkdraft BC CDA Result Organizer (V3) (2.1)2019‑03‑16 19:52:40
2.16.840.1.113883.10.20.22.2.101linkdraft BC CDA Referral Note (V2) (2.1)2019‑04‑06 02:03:17
2.16.840.1.113883.10.20.22.4.7linkdraft Allergy - Intolerance Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.9linkdraft Reaction Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.12linkdraft Procedure Activity Act (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.13linkdraft Procedure Activity Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.14linkdraft Procedure Activity Procedure (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.16linkdraft Medication Activity (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.30linkdraft Allergy Concern Act (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.35linkcancelled Discharge Medication (V3) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.35linkdraft Discharge Medication (V3) (2.1)2016‑03‑01
2.16.840.1.113883.10.20.22.4.36linkdraft Admission Medication (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.43Containmentdraft Planned Supply (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.50Containmentdraft Non-Medicinal Supply Activity (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.52linkdraft Immunization Activity (V3) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.66linkdraft Functional Status Organizer (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.67linkdraft Functional Status Observation (V2) (2.1)2014‑06‑09
2.16.840.1.113883.10.20.22.4.130linkdraft Nutrition Recommendation (2.1)2015‑08‑13
2.16.840.1.113883.10.20.22.4.131linkdraft Intervention Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.132linkdraft Health Concern Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.135linkdraft Medical Equipment Organizer (2.1)2015‑08‑13
2.16.840.1.113883.10.20.22.4.136linkdraft Risk Concern Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.22.4.146linkdraft Planned Intervention Act (V2) (2.1)2015‑08‑01
2.16.840.1.113883.10.20.24.3.90linkdraft Substance or Device Allergy - Intolerance Observation (V2) (2.1)2014‑06‑09
BeziehungSpezialisierung: Template 2.16.840.1.113883.10.12.321 CDA Participant (Body) (2005‑09‑07)
ref
ad1bbr-
ItemDTKardKonfBeschreibungLabel
cda:participantRole
Proddotsance
@classCode
cs1 … 1FMANUCONFdots7900
 en-US SHALL contain exactly one [1..1] @classCode="MANU" Manufactured Product (CodeSystem: RoleClass urn:oid:2.16.840.1.113883.5.110 STATIC) (CONF:81-7900).
cda:templateId
II1 … 1Men-US SHALL contain exactly one [1..1] templateId (CONF:81-7901) such that itCONFdots7901
@root
uid1 … 1F2.16.840.1.113883.10.20.22.4.37CONFdots0522
 en-US SHALL contain exactly one [1..1] @root="2.16.840.1.113883.10.20.22.4.37" (CONF:81-10522).
cda:id
II1 … *en-US SHALL contain at least one [1..*] id (CONF:81-7902).CONFdots7902
cda:playingDevice
1 … 1Men-US SHALL contain exactly one [1..1] playingDevice (CONF:81-7903).CONFdots7903
cda:code
0 … 1Ren-US This playingDevice SHOULD contain zero or one [0..1] code (CONF:81-16837).CONFdots6837
cda:scopingEntity
1 … 1Men-US SHALL contain exactly one [1..1] scopingEntity (CONF:81-7905).CONFdots7905
cda:id
II1 … *en-US This scopingEntity SHALL contain at least one [1..*] id (CONF:81-7908).CONFdots7908